About Us
Stroke
Our product
Partners & Investors
News & Media
Contact

About Us

Nothing to display, yet.

About Us

Company Overview
Management Team
Project Team
Board of directors

June 14, 2018

ACTICOR BIOTECH CONFIRMS SIMBEC-ORION TO MAKE ITS FIRST IN PATIENT STUDY IN ACUTE ISCHEMIC STROKE

Paris, June 14, 2018 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including stroke and pulmonary embolism, as part of the development of its first drug candidate ACT017 who has just successfully completed a phase 1 study in the healthy volunteer, confided to Simbec-Orion carrying out his […]

Main navigation

About Us
Stroke
Our product
Press Releases
Media Coverage
Publications
Investors

Contact

Contact Us
Follow us on Twitter
Follow us on LinkedIn

Acticor Biotech
Bâtiment Inserm U1148
Hôpital Bichat, Secteur Claude Bernard
46 rue Henri Huchard
75877 Paris Cedex 18